Corrections

Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation

BMJ 2001; 322 doi: (Published 10 March 2001) Cite this as: BMJ 2001;322:587

In this paper by Taylor et al (20 January, pp 321-6) the name of the drug used in antiplatelet treatment should have been indobufen, not indoprofen. Indoprofen was withdrawn from use worldwide after reports of carcinogenicity in animal studies.

Footnotes

View Abstract